Beyond intellectual property: lessons on local manufacturing, collaboration, and policy from the pandemic era

Burcu Kilic

Chapter 25 in Handbook of Innovation and Intellectual Property Rights, 2024, pp 440-452 from Edward Elgar Publishing

Abstract: This chapter builds upon over two decades of research and advocacy in intellectual property and access to medicines, informed by COVID-19 insights. It explores how developing countries struggled with local manufacturing capacity after the TRIPS Agreement, and highlights how the pandemic has exposed the limitations of TRIPS. The author, an experienced access-to-medicines lawyer, assesses pharmaceutical companies’ influence on global IP policies, TRIPS-plus impacts, and the effects of limited local manufacturing capacity. Advocating for a revisiting of the global IP regime in response to global health challenges, the chapter underscores the importance of robust local manufacturing capacity and effective technology transfer. It provides an in-depth analysis of lessons from the pandemic, emphasizing policy reforms and the TRIPS Waiver’s role in addressing health emergencies.

Keywords: Business and Management; Economics and Finance; Innovations and Technology; Law - Academic (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.elgaronline.com/doi/10.4337/9781800880627.00035 (application/pdf)
Our link check indicates that this URL is bad, the error code is: 503 Service Temporarily Unavailable

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:elg:eechap:20438_25

Ordering information: This item can be ordered from
http://www.e-elgar.com

Access Statistics for this chapter

More chapters in Chapters from Edward Elgar Publishing
Bibliographic data for series maintained by Darrel McCalla ().